Sheldon L. Koenig, President and CEO at Esperion Therapeutics, Inc. (ESPR), sold 3,394 shares at $6.94 ($24K) on 2022-09-19, disclosed to the SEC on 2022-09-20.
Open-market sale of $24k ESPR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ESPR | SELL | 2025-12-18 | $354K | — | Filing → |
| ESPR | SELL | 2025-09-18 | $159K | — | Filing → |
| ESPR | SELL | 2025-06-18 | $34K | — | Filing → |